dm+d

1389007

Articles

Safety in Lactation: Corticosteroids

9 November 2020There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…

Safety in Lactation: Drugs used in nasal allergy

27 October 2020Drugs used for nasal allergy have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…

Safety in Lactation: Drugs for obstructive airways disease

25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to…

Safety in Lactation: Topical corticosteroids

23 September 2020Topical corticosteroids are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid direct contact of the…

Safety in lactation: Drugs for chronic bowel disorders

21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Search Articles

Medicine Compliance Aid Stability

ClipperChiesi Ltd

Chiesi Ltd
Clipper
Tablets m/r 5mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from light
Protect from light.
22 October 2015

Lactation Safety Information

Inhalation

Inhalation
Yes
-
Synonym: Beclomethasone
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
23 September 2020

Intranasal

Intranasal
Yes
23 September 2020

Topical

Topical
Yes
High potency
23 September 2020

Oral for inflammatory bowel disease

Oral
for inflammatory bowel disease
Yes
Rectal hydrocortisone/ prednisolone/ budesonide
Synonym: beclomethasone
No published evidence of safety after oral administration of sustained release tablets
Low levels anticipated in milk due to the drug’s properties
23 September 2020

New Medicines

QvarAsthma in children aged 5 to 12 years

Information

Qvar
Licence extension / variation
Teva

Development and Regulatory status

Launched
Launched
None
November 2019
Nov 19Licence change approved by MHRA to expand use to children aged 5 to 12 years (previously approved for use in children aged 12 years and old, adolescents and adults). The approved indication is use in children aged 5 and over, adolescents and adults for the prophylactic management of mild, moderate or severe asthma [2].

Category

Inhaled corticosteroid
According to Asthma UK, 5.4 million people in the UK receive treatment for asthma: 1 in 11 children and 1 in 12 adults [1].
Asthma in children aged 5 to 12 years
Inhalation